Pfizer Partners With Gavi to Supply Our Vaccine to 50 Countries
Annually, pneumococcal disease kills about 1 million children worldwide. Children younger than 5 years old in low income countries are 89 times more likely to die from the disease than children in high income countries.[i] Pfizer is partnering with Gavi, the Vaccine Alliance, to supply our vaccine to 50 countries across Africa, Asia, Latin America, the Middle East and parts of Europe. That means, on average, we have introduced the vaccine into five new country National Immunization Programs per year for the last 10 years. Pfizer believes that to tackle the challenge of pneumonia, our work doesn't end with supplying our vaccine. We also ensure the vaccine can reach those who need it the most by helping to train nearly 40,000 health care workers across Asia and Africa, who are at the forefront of immunizing babies.